SynthesisJournal of medical virology2021

Tocilizumab administration is associated with the reduction in biomarkers of coronavirus disease 2019 infection.

Timotius Ivan Hariyanto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.